Company Data

Poseida Therapeutics Inc.

Ticker
PSTX
Current Price
$9.5
Market Cap
$925.9M
Price Target
Refer to Report
Volume
124.7K
52wk Range
$1.87 - $9.67
Advanced Market Data

Overview

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy